Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02807272
Title Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia (CMML)
Acronym CMML/AML
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kura Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Arizona Scottsdale Arizona 85054 United States Details
Mayo Clinic Florida Jacksonville Florida 32224 United States Details
H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa Florida 33612 United States Details
Johns Hopkins University Baltimore Maryland 21231 United States Details
Mayo Clinic Rochester Rochester Minnesota 55905 United States Details
Weill Cornell Medicine New York New York 10065 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
University of Pennsylvania Hospital Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field